Raymond James Financial
ARKG icon

Raymond James Financial’s ARK Genomic Revolution ETF ARKG Stock Holding History

Raymond James Financial’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$15.7M Buy
374,233
+191,646
+105% +$6.1M ﹤0.01% 1751
2026
Q1 		$4.82M Buy
182,587
+30,105
+20% +$882K ﹤0.01% 2618
2025
Q4 		$4.42M Buy
152,482
+9,851
+7% +$296K ﹤0.01% 2621
2025
Q3 		$3.96M Buy
142,631
+3,549
+3% +$89.7K ﹤0.01% 2630
2025
Q2 		$3.39M Sell
139,082
-3,280
-2% -$71.9K ﹤0.01% 2663
2025
Q1 		$2.96M Buy
142,362
+56,283
+65% +$1.41M ﹤0.01% 2699
2024
Q4 		$2.03M Buy
+86,079
New +$2.12M ﹤0.01% 2965

Other funds holding ARKG

JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
JFG
Jefferies Financial Group New York $15.2B AUM 55.75% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State of Wisconsin Investment Board
State of Wisconsin Investment Board Madison, Wisconsin $49.6B AUM 39.59% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return

Raymond James Financial's ARKG Position: Q2 2026 in Review

Raymond James Financial increased its ARK Genomic Revolution ETF (ARKG) stake by 105% in Q2 2026, buying an estimated $6.1M and bringing the position to 374,233 shares worth $15.7M. The position accounts for ﹤0.01% of the portfolio, ranked #1751.

Raymond James Financial first reported a position in ARKG in Q4 2024 and has held it in 7 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Raymond James Financial held 374,233 shares of ARK Genomic Revolution ETF worth $15.7M as of Q2 2026.
  • Raymond James Financial bought 191,646 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $6.1M.
  • ARK Genomic Revolution ETF made up ﹤0.01% of Raymond James Financial's portfolio in Q2 2026, its #1751 holding.
  • Raymond James Financial first reported a position in ARK Genomic Revolution ETF in Q4 2024 and has held it in 7 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Raymond James Financial's 13F filing for Q2 2026, filed 14 Aug 2026.